US FDA Asks Manufacturers To Fix Disruption In Isotretinoin REMS

 
• By Brenda Sandburg
  
Modified REMS for acne drug isotretinoin faces delays in implementation • Source: Alamy

More from Drug Safety

More from Pink Sheet